TOKYO (Reuters) - Japan's Konica Minolta said on Thursday it was purchasing U.S.-based testing company Ambry Genetics in a deal valued at up to $1 billion.

Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion
Read More
Bagikan Berita Ini
0 Response to "Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion"
Posting Komentar